CurATime is developing an innovative platform called curAHub, aiming to facilitate the use, processing, and value creation from biodata. This platform will provide access to high-quality, standardized biological and (sub)clinical data for commercial and academic institutions. With a focus on biostatistical and bioinformatic evaluation methods, curAHub seeks to transform the biomedical research landscape.
- Name: curAHub
- Duration: March 1, 2023 – February 28, 2026
- Project partners:
- Deutsches Zentrum für Künstliche Intelligenz GmbH (DFKI)
- Universitätsmedizin Mainz Centrum für Thrombose und Hämostase (CTH)
- Symptoma GmbH (SYM)
- ARXUM GmbH (ARXUM)
- TRON gGmbH (TRON)
- Funded by: German Federal Ministry of Education and Research
- Project website: curatime.org
- Develop a central biodata platform, the Gutenberg Innovation Hub
- Utilize blockchain technology to regulate data access
- Ensure strictly regulated access and state-of-the-art data protection management
- Continuously develop and establish innovative biostatistical and bioinformatic evaluation methods
- Address the challenge of atherothrombosis-related cardiovascular diseases
- Develop customized treatment and prevention concepts for cardiovascular diseases
- Identify biomarker profiles and risk factors using individualized and subgroup-specific approaches
- Develop diagnostic, preventive, and therapeutic concepts, including novel algorithms to improve therapy selection and risk assessment
- Create eHealth apps and smart devices for better management of cardiovascular diseases
Cardiovascular diseases are among the leading causes of death worldwide, with atherothrombosis being the pathological basis for almost all of these diseases. Despite some progress in recent decades, there has been a stagnation in the improvement of the prognosis for cardiovascular diseases, and even a reversal of this trend in some population groups. As a result, there is an urgent need for better understanding and management of risk factors and biomarkers, which curAHub seeks to address.